WW Wonks: What happened at the rescheduling hearings?

Following President Donald Trump's decision to move MED to schedule III, the DEA hosted hearings this month on whether REC should be rescheduled as well. While the outcome has significant implications for the industry, especially with regard to industry-hated tax rule 280E and interstate trade, the hearings revolved largely around questions of weed's medical value.

Drug historian Emily Dufton covered the hearings . . .